![](https://www.pharmaceutical-technology.com/wp-content/themes/goodlife-wp-B2B/images/WhitePaper_Default_icon.png)
Dose Counters and Indicators
By H&T Presspart
Providing methods for predicting the end-of-life of pressurised metered dose inhalers (pMDI) and incorporating mobile health (mHealth) technology would improve patient safety considerably.
H&T Presspart's global business development manager Ingra Meyer and technical applications engineer Kyle Wilson explain how their dose counter-enabled inhaler development work has led to the production of a system that accurately indicates the end-of-life of a device.
![](https://www.pharmaceutical-technology.com/wp-content/themes/goodlife-wp-B2B/images/WhitePaper_Default_icon.png)